Sex Does Not Influence Prognosis in Diabetic Patients. The Barbanza Diabetes Study;El sexo no condiciona diferencias en el pronóstico de pacientes diabéticos. Estudio Barbanza-Diabetes

Revista Espanola de Cardiologia

Volumn 63, Issue 2, 2010, Pages 170-180

  Vidal Pérez, Rafael ^a   Otero Raviña, Fernando ^b   Grigorian Shamagian, Lilian ^a   Parga García, Vicente ^c   Eirís Cambre, María J ^d   De Frutos De Marcos, Concepción ^e   Caneda Villar, Carmen ^f   de la Fuente Mariño, Rosa ^g   Ramos González, Ana ^h   González Juanatey, José R ^a  

^a University Hospital of Santiago de Compostela   (Spain)

^b Servicio Galego de Saúde   (Spain)

^c Centro de Salud Ribeira A Coruña España   (Spain)

^d Centro de Salud Muros A Coruña España   (Spain)

^e Centro de Salud Padrón A Coruña España   (Spain)

^f Centro de Salud Rois A Coruña España   (Spain)

^g Centro de Salud Rianxo A Coruña España   (Spain)

^h Centro de Salud Federico Tapia A Coruña España   (Spain)

Author keywords

Diabetes mellitus; Ischemic heart disease; Primary care; Prognosis; Sex

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; CHOLESTEROL; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PHYSICIAN; PRIMARY MEDICAL CARE; PROGNOSIS; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SPAIN; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 76749152235     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/S0300-8932(10)70035-X     Document Type: Article

References (33)

1. González-Juanatey J.R., Alegría-Ezquerra E., García-Acuña J.M., González-Maqueda I., and Lozano J.V. Impacto de la diabetes en las enfermedades cardíacas en España. Estudio CARDIOTENS 1999. Med Clin (Barc) 116 (2001) 686-691
2. González-Clemente J.M., Palma S., Arroyo J., Vilardell C., Caixás A., Jiménez-Palop O., et al. ¿La diabetes mellitus es un equivalente de riesgo coronario? Resultados de un metaanálisis de estudios prospectivos. Rev Esp Cardiol 60 (2007) 1167-1176
3. Masiá R., Sala J., Rohlfs I., Piulats R., Manresa J.M., and Marrugat J. Prevalencia de diabetes mellitus en la provincia de Girona, España: el estudio REGICOR. Rev Esp Cardiol 57 (2004) 261-264
4. Valdés S., Rojo-Martínez G., and Soriguer F. Evolución de la prevalencia de diabetes tipo 2 en población adulta española. Med Clin (Barc) 129 (2007) 352-355
5. Eckel R.H., Kahn R., Robertson R.M., and Rizza R.A. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation 113 (2006) 2943-2946
6. Pilote L., Dasgupta K., Guru V., Humphries K.H., McGrath J., Norris C., et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 176 (2007) S1-44
7. Marrugat J., Sala J., and Aboal J. Epidemiología de las enfermedades cardiovasculares en la mujer. Rev Esp Cardiol 59 (2006) 264-274
8. Gu K., Cowie C.C., and Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 281 (1999) 1291-1297
9. Huxley R., Barzi F., and Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: metaanalysis of 37 prospective cohort studies. BMJ 332 (2006) 73-78
10. Kanaya A.M., Grady D., and Barrett-Connor E. Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med 162 (2002) 1737-1745
11. Graham M.M., Ghali W.A., Faris P.D., Galbraith P.D., Norris C.M., Knudtson M.L., and APPROACH Investigators. Sex differences in the prognostic importance of diabetes in patients with ischemic heart disease undergoing coronary angiography. Diabetes Care 26 (2003) 3142-3147
12. González-Juanatey J.R., Mazón-Ramos P., Allut-Vidal G., Pérez-Llamas M., Blanco-Rodríguez R., Pastor-Benavent M.C., et al. Control of vascular and renal risk factors in diabetic patients. Results of the Barbanza Diabetes Eductional Programme. Eur J Gen Pract 10 (2004) 109-110
13. González-Juanatey J.R., Grigorian-Shamagian L., Juiz-Crespo M.A., Sánchez-Loureiro M., Rodríguez-Moldes E., Dopico-Pita J., et al. Impacto pronóstico de la localización de la enfermedad aterosclerosa previa en pacientes diabéticos. Estudio Barbanzadiabetes. Rev Esp Cardiol 61 (2008) 1168-1177
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. American Diabetes Association: clinical practice recommendations 2002. Diabetes Care 25 Suppl 1 (2002) 1-147
15. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24 (2003) 1601-1610
16. Muñiz J., López-Rodríguez I., Gabriel-Sánchez R., Juane R., Montiel-Carracedo M.D., López-Quintela A., et al. Evidencia de presiones arteriales más elevadas en niños y adolescentes del interior rural de Galicia que en otras localizaciones en España. Rev Esp Cardiol 51 (1998) 823-831
17. Tomás i Abadal L., Varas Lorenzo C., Pérez I., Puig T., and Balaguer Vintró I. Factores de riesgo y morbimortalidad coronaria en una cohorte laboral mediterránea seguida durante 28 años. Estudio de Manresa. Rev Esp Cardiol 54 (2001) 1146-1154
18. Ríus-Riu F., Salinas Vert I., Lucas-Martín A., Romero-González R., and Sanmartí-Sala A. A prospective study of cardiovascular disease in patients with type 2 diabetes. 6.3 years of follow-up. J Diabetes Complications 17 (2003) 235-242
19. Cañón-Barroso L., Cruces-Muro E., Fernández-Ochoa G., Nieto-Hernández T., García-Vellido A., and Buitrago F. Validación de tres ecuaciones de riesgo coronario en población diabética de un centro de salud. Med Clin (Barc) 126 (2006) 485-490
20. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 161 (2001) 1717-1723
21. Liao Y., Cooper R.S., Ghali J.K., Lansky D., Cao G., and Lee J. Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease. Diabetes Care 16 (1993) 708-713
22. Lee W.L., Cheung A.M., Cape D., and Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 23 (2000) 962-968
23. Howard B.V., Cowan L.D., Go O., Welty T.K., Robbins D.C., and Lee E.T. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21 (1998) 1258-1265
24. Haffner S.M., Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234
25. Schramm T.K., Gislason G.H., Køber L., Rasmussen S., Rasmussen J.N., Abildstrøm S.Z., et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 117 (2008) 1945-1954
26. Dale A.C., Nilsen T.I., Vatten L., Midthjell K., and Wiseth R. Diabetes mellitus and risk of fatal ischaemic heart disease by gender: 18 years follow-up of 74,914 individuals in the HUNT 1 Study. Eur Heart J 28 (2007) 2924-2929
27. Natarajan S., Liao Y., Cao G., Lipsitz S.R., and McGee D.L. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Arch Intern Med 163 (2003) 1735-1740
28. Gouni-Berthold I., Berthold H.K., Mantzoros C.S., Böhm M., and Krone W. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care 31 (2008) 1389-1391
29. Ferrara A., Mangione C.M., Kim C., Marrero D.G., Curb D., Stevens M., et al. Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study. Diabetes Care 31 (2008) 69-74
30. Conthe P., Lobos J.M., González-Juanatey J.R., Gil A., Pajuelo J., and Novials A. Diferencias en la atención de las mujeres con alto riesgo cardiovascular respecto a los varones: estudio multidisciplinar. Med Clin (Barc) 120 (2003) 451-455
31. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
32. Weir M.R. Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2 (2007) 581-590
33. Natarajan S., Liao Y., Sinha D., Cao G., McGee D.L., and Lipsitz S.R. Sex differences in the effect of diabetes duration on coronary heart disease mortality. Arch Intern Med 165 (2005) 430-453